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Background: Various inflammatory mediators related to obesity might be closely related to insulin resistance.
Leukotrienes (LTs) are involved in inflammatory reactions. However, there are few reports regarding the role of LTs
in adipocyte differentiation. Therefore, we investigated the role of leukotriene B4 (LTB4)-leukotriene receptor (BLT)
signaling in mouse 3T3-L1 fibroblastic preadipocyte differentiation to mature adipocytes.
Methods: Mouse 3T3-L1 preadipocytes were treated with lipoxygenase (LOX) inhibitors, BLT antagonist, and small
interfering RNA (siRNA) for BLT1 and BLT2 to block the LTB4-BLT signaling pathway, then the adipocyte
differentiation such as lipid accumulation and the increase in triglyceride was evaluated.
Results: Blockade of BLT signaling by treatment with a LOX inhibitor or a BLT antagonist suppressed preadipocyte
differentiation into mature adipocytes. In addition, knockdown of BLT1 and BLT2 by siRNAs dramatically inhibited
differentiation. These results indicate the LTB4-BLT signaling pathway may positively regulate preadipocyte
differentiation and be a rate-limiting system to control adipocyte differentiation.
Conclusions: The LTB4-BLT signaling pathway provides a potent regulatory signal that accelerates the differentiation
of mouse 3T3-L1 preadipocytes. Further investigations are necessary to confirm the exact role of LTB4 and BLTs
signaling pathways in preadipocyte differentiation.
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Diabetes mellitus, hyperlipidemia, hypertension, and ath-
erosclerosis have recently been defined as typical life style-
related diseases. A common background of these diseases
is obesity, which is thought to cause insulin resistance
resulting in the onset of disease [1,2]. Recently, the inci-
dence of obesity and associated metabolic syndrome has
dramatically increased. Although high caloric western-style
foods are believed to be the main cause of this dramatic in-
crease, other possible risk factors could exist. The involve-
ment of various inflammatory mediators such as tumor
necrosis factor alpha (TNFα) and interleukin 6 (IL-6) on
obesity might be closely related to insulin resistance [1-4].
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reproduction in any medium, provided the orresistance are the adipose tissues, as adipocytes generate
adipocytokines that are important in the onset of metabolic
syndrome [1,2,5].
Leukotrienes (LTs) such as leukotriene B4, C4, and
D4 (LTB4, LTC4, and LTD4, respectively) are generated
through lipoxygenase (LOX) pathways and induce in-
flammatory and allergic reactions such as leukocyte acti-
vation, capillary permeability, and bronchial contraction
[6,7]. LTB4 binds to specific receptors, BLT1 and BLT2, to
activate signaling pathways [8,9]. LTs have been reported to
be involved in the proliferation of epithelial, endothelial
and mesangial cells [10,11]. In addition, we previously
reported that LTB4 controls immature neural stem cell
proliferation and differentiation via the BLT signaling
pathway [12]. Thus, LTB4 and its signaling pathway
might be involved in cell proliferation and differentiation.
However, there have been few reports regarding the role
of LTs in adipocyte differentiation.
In this study, we investigated the role of LTB4 and
BLTs signaling pathways in preadipocyte differentiationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cell line for research of preadipocyte differentiation [13].
We analyzed the effects of LOX inhibitors, a BLT antag-
onist and BLTs-specific siRNAs on the differentiation of
3T3-L1 to clarify the function of BLTs on preadipocyte
differentiation. Our results suggest a potentially import-
ant and novel role for LTB4 and BLT functions on pre-
adipocyte differentiation.
Results
Effects of LOX inhibitors and BLT antagonist on mouse
3T3-L1 preadipocyte differentiation
Mouse 3T3-L1 cells can differentiate from fibroblastic
cells into mature adipocytes in induction medium for
differentiation containing insulin (INS), dexamethasone
(DEX), 3-isobutyl-1-methylxanthine (IBMX) and rosiglita-
zone (ROSI), a specific ligand for peroxisome proliferator-
activated receptor gamma (PPARγ) [13,14]. We used these
induction conditions for the differentiation of mouse 3T3-
L1 preadipocytes (Figure 1). Nordihydroguaiaretic acid
(NDGA), a pan-LOX inhibitor, inhibited the accumula-
tion of lipids, the decrease of triacylglycerol (TG) contents
and the index of mouse 3T3-L1 preadipocyte differenti-
ation into mature adipocytes (Figure 2A). No alterations
in cell proliferation were observed under our experimen-
tal conditions (data not shown). AA-861, a 5-LOX inhibi-
tor, also inhibited the differentiation of mouse 3T3-L1
preadipocytes into mature adipocytes (Figure 2B). ThesePreadipocyte Adipocyte
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Figure 1 Schematic protocol for mouse 3T3-L1 preadipocyte
differentiation.suppressive effects occurred in a concentration-dependent
manner. In addition, ONO-4057, a specific LTB4 recep-
tor antagonist, suppressed mouse 3T3-L1 preadipocyte
differentiation (Figure 2C). These results suggest that the
LTB4-BLT signaling pathway may be involved in pre-
adipocyte differentiation.
Effect of BLT1 and BLT2 knockdown by siRNA on mouse
3T3-L1 preadipocyte differentiation
To investigate whether BLTs are expressed on pre-
adipocytes, we performed western blot analysis, which
showed that both BLT1 and BLT2 were expressed in
mouse 3T3-L1 preadipocytes from the start to late
phases of differentiation (Figure 3). In addition, the
level of LTB4 secreted from preadipocytes into the cul-
ture medium was 31.8 ± 8.4 nmol/L (mean ± SEM, n=3).
These results indicate that the BLT-signaling pathway
induces the differentiation of preadipocytes to mature
adipocytes.
Therefore, we designed siRNAs specific for BLT1 or
BLT2 to knockdown receptor expression. siRNAs against
BLT1 and BLT2 successfully suppressed the expres-
sion of BLT1 and BLT2 (Figure 4A). Indicators of pre-
adipocyte differentiation such as lipid accumulation and
TG contents were decreased by BLT1 siRNA (Figure 4B
and C). Similar results were observed with BLT2 siRNA
(Figure 4D and E). These results clearly indicated that
the LTB4-BLT signaling pathway accelerates mouse 3T3-
L1 preadipocyte differentiation, and blockade or knock-
down of BLTs leads to the suppression of preadipocyte
differentiation.
Combination knockdown of BLT1 and BLT2 by siRNA on
mouse 3T3-L1 preadipocyte differentiation
To clarify the role of each receptor, BLT1 and BLT2, on
adipocyte differentiation, we performed combination
treatment of BLT1-siRNA and BLT2-siRNA. The com-
bined treatment of BLT1-siRNA (12.5 nM) and BLT2-
siRNA (12.5 nM) remarkably decreased lipid accumulation
and TG contents in comparison to single knockdown
(Figure 5A and B) indicating that combination knockdown
of BLT1 and BLT2 by specific siRNA efficiently suppressed
preadipocyte differentiation.
Discussion
The mouse fibroblastic 3T3-L1 cell line established by
Green is widely used for the investigation of adipocyte
differentiation [13,15,16]. The involvement of various
molecules for adipocyte differentiation has been investi-
gated using this cell line. However, it is not fully under-
stood whether inflammation-related lipid mediators, such
as LTs and prostaglandins (PGs), promote or inhibit the
onset of metabolic syndrome. Several previous reports in-






























































































Figure 2 Effects of LOX inhibitors and the BLT antagonist on mouse 3T3-L1 preadipocyte differentiation. (A), (B) and (C): Effects of
NDGA (LOX inhibitor, A), AA-861 (5-LOX inhibitor, B), or ONO-4057 (a specific BLT antagonist, C) on lipid accumulation in mouse 3T3-L1
preadipocytes. Mouse 3T3-L1 preadipocytes were treated with NDGA, AA-861 or ONO-4057 for 6 days. Then, accumulation of triacylglycerol (TG),
a marker of lipid accumulation (bottom panel), in matured adipocytes was measured and expressed as TG contents (μg/mg protein). Each
column represents the mean ± SEM from 4-8 independent experiments. *P<0.05, **P<0.01 vs. vehicle control. Upper left panel shows
representative photographs of differentiated mouse 3T3-L1 preadipocytes treated with vehicle for 6 days. Upper right panel shows representative
photographs of undifferentiated mouse 3T3-L1 preadipocytes treated with NDGA, AA-861 or ONO-4057 for 6 days. Cells were stained with Oil
Red O method to visualize lipid accumulation. Scale bar represents 100 μm.
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way [17,18]. Therefore, cyclooxygenase-related prostanoids
are considered involved in the enhancement of adipocyte
differentiation. In contrast, there have been few reports re-
garding the involvement of LOX-related metabolites in adi-
pocyte differentiation.
In this study, 5-LOX inhibitors and a specific LTB4 re-
ceptor antagonist inhibited the differentiation of mouse3T3-L1 preadipocytes into mature adipocytes. Further-
more, BLT1 and BLT2 knockdown by siRNA suppressed
mouse 3T3-L1 preadipocyte differentiation. In addition,
combination knockdown of BLT1 and BLT2 by siRNA
on mouse 3T3-L1 preadipocytes remarkably decreased
lipid accumulation and TG contents in comparison
to single knockdown alone. These results clearly indi-






Figure 3 Expression of BLT1 and BLT2 during preadipocyte
differentiation. Detection of BLT1 and BLT2 was performed by
western blot analysis using anti-BLT1 or -BLT2 antibodies. GAPDH
was used as an internal standard for confirmation of equally applied
amounts of protein.
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ade or knockdown of BLTs leads to the suppression of
preadipocyte differentiation.
Furthermore, we demonstrated that both LTB4 recep-
tors, BLT1 and BLT2, were expressed in mouse 3T3-L1
preadipocytes. We also confirmed the release of LTB4
from preadipocytes into the culture medium. These re-
sults indicate that a paracrine or autocrine pathway of
BLT-signaling operates in preadipocytes, for the positive
regulation of mouse 3T3-L1 preadipocyte differentiation
from adipocyte progenitors, because inhibition of this
pathway with LOX inhibitors, a BLT antagonist, or
siRNAs for BLTs induced the inhibition of preadipocyte
differentiation.
Interestingly, a recent paper showed that deletion of
BLT1 protected mice from high-fat diet-induced insulin
resistance [19]. Such observations clearly show that
BLT1 signaling is closely involved in insulin resistance.
However, the results of a BLT1 knockout mouse study
were considered to be due to systemic mechanisms.
Therefore, the local action of BLT1 signaling on adipose
tissues should be investigated. Our present data using
3T3-L1 adipocytes may partly support these previous
observations. To clarify the issue, an adipocyte specific
BLT1-conditional knockout mouse study is required.
The involvement of BLT1 signaling may be important
for adipocyte differentiation and related systemic disor-
ders such as insulin resistance and obesity.
To investigate the potential mechanisms of BLT
signaling-mediated acceleration of 3T3-L1 preadipocyte
differentiation, we performed DNA microarray ana-
lysis to identify the molecules regulated by LTB4-BLT
signaling. Many molecules were significantly altered
by treatment with a 5-LOX inhibitor, AA-861 or a specific
BLT antagonist, ONO-4057 (unpublished data). Amongthem, we initially focused on the expressions of PPARγ
and CCAAT-enhancer-binding protein, alpha (C/EBPα)
which is known as important key transcriptional regu-
lators to control adipocyte differentiation. However, both
molecules did not show significant changes at the micro-
array analysis. Namely, increase in PPARγ expression
was from 0.9 to 1.3-fold, that in C/EBPα expression was
from 0.7 to 1.1-fold, respectively. Therefore, it is expected
that LTB4-BLT signaling pathway promoted 3T3-L1
preadipocyte differentiation via other molecules inde-
pendent to PPARγ or C/EBPα. Further investigations will
be required to clarify the molecules.
In conclusion, the LTB4-BLT signaling pathway pro-
vides a potent regulatory signal that accelerates the dif-
ferentiation of mouse 3T3-L1 preadipocytes. Our results
imply a potentially important and novel role for LTB4
and BLT functions on preadipocyte differentiation. Fur-
ther investigations are necessary to confirm the exact role




INS, DEX and IBMX were purchased from Sigma Japan
(Tokyo, Japan). ROSI was purchased from GlaxoSmith
Kline K. K. (Tokyo, Japan). LT synthetase, LOX inhibitor,
NDGA, and 5-LOX specific inhibitor, AA-861, were pur-
chased from Sigma Japan. ONO-4057, a specific BLT an-
tagonist, was a kind gift from ONO Pharmaceutical Co.
Ltd. (Osaka, Japan). Anti-BLT1 and -BLT2 polyclonal
antibodies were purchased from Cayman Chemicals (Ann
Arbor, MI, USA).
Cell culture and induction of adipocyte differentiation
Mouse 3T3-L1 preadipocytes have been frequently
used to study the differentiation of preadipocytes in vitro.
Cell culture and induction of differentiation of pre-
adipocytes were performed according to the previously
described method (Figure 1) [14,20]. Briefly, mouse 3T3-
L1 preadipocytes were cultured in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma Japan) supplemented
with 10% fetal bovine serum, 1% MEM non-essential
amino acids, 100 IU/mL penicillin and 0.1 mg/mL strepto-
mycin. At 3 days after reaching confluency (day 0),
the medium was replaced with induction medium for
differentiation containing INS (150 nM), DEX (1 μM),
IBMX (100 μM) and ROSI (PPARγ-ligand, 1 μM). The
differentiation medium was changed every 4 days until
analysis (day 6).
The LOX inhibitor (NDGA/AA-861) or specific BLT
antagonist (ONO-4057) was prepared in dimethyl sulf-
oxide (DMSO, Sigma Japan) and added to the differen-
tiation medium from day 0 to day 6 (Figure 1). The
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Figure 4 Effect of BLT1 and BLT2 knockdown by siRNA on mouse 3T3-L1 preadipocyte differentiation. (A): Confirmation of BLT1 and
BLT2 knockdown by specific siRNAs. Negative control is cells treated with negative control siRNA (Stealth RNAi Negative Control Duplexes).
(B) and (C): Effect of BLT1 knockdown by siRNA. Representative microscopic (B) images of differentiated mouse 3T3-L1 adipocytes by Oil
Red O staining. Scale bar represents 100 μm. (C): Accumulation of TG in mature adipocytes was measured and expressed as TG contents
(μg/mg protein). Each column represents the mean ± SEM from 3-5 independent experiments. *P<0.05 vs. negative control-siRNA treatment.
(D) and (E): Effect of BLT2 knockdown by siRNA. Representative microscopic (D) images of differentiated mouse 3T3-L1 adipocytes by Oil
Red O staining. Scale bar represents 100 μm. (E): Accumulation of TG in mature adipocytes was measured and expressed as TG contents
(μg/mg protein).
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strated no significant effects of 0.1% DMSO on cell
differentiation.
Evaluation of adipocyte differentiation
Differentiation of preadipocytes to mature adipocytes
was visually monitored by microscopic observation after
Oil red O staining [14,15]. In addition, the amount of
triglyceride, an index of lipid accumulation, was quan-
titatively measured using a Triglyceride E-test Wako
kit (Wako Pure Chemicals, Tokyo, Japan). The amountof triglyceride was normalized by protein amount and
expressed as TG contents (μg/mg protein).
siRNA for knockdown of BLT1 and BLT2
We designed small interfering RNA (siRNA) for knock-
down of BLT1 and BLT2 using an siRNA system (Qiagen,
Tokyo, Japan). The sequences of the sense and anti-
sense strand for BLT1 used were 5’-CAACCUACAC
UUCCUAUUA-3’, and 5’-UAAUAGGAAGUGUAGGU
UG-3’, respectively. The sequences of the sense and
antisense strand for BLT2 used were 5’-GGGACUUA
BNegative control-siRNA 25nM







































Figure 5 Combination knockdown of BLT1 and BLT2 by siRNA on mouse 3T3-L1 preadipocyte differentiation. Mouse 3T3-L1
preadipocytes were treated with a combination of BLT1-siRNA (12.5 nM) and BLT2-siRNA (12.5 nM). (A): Representative microscopic images of
differentiated mouse 3T3-L1 adipocytes by Oil Red O staining. Scale bar represents 100 μm. (B): Accumulation of TG in mature adipocytes was
measured and expressed as TG contents (% of negative control). Each column represents the mean ± SEM from 3 independent experiments.
*P<0.05, **P<0.01 vs. negative control-siRNA treatment.
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UCCG-3’, respectively.
For transfection, siRNAs or negative control siRNA
(Stealth RNAi Negative Control Duplexes, Invitrogen,
Tokyo, Japan) were combined with Lipofectamine
RNAiMAX (Invitrogen) and incubated for 20 minutes at
room temperature to produce the transfection mixture.
Then, the transfection mixture was added to preadipocytes
at a final concentration of 25, 50 and 100 nM siRNA
(Figure 1). At 24 hours after the start of transfection, the
medium was replaced with differentiation medium to in-
duce differentiation. Samples were collected at days 1, 2, 3and 5 day for western blot analysis, and at day 6 for TG
assay and Oil red O staining.
Statistical analysis
Results were expressed as the mean ± SEM. Statistical
comparisons were performed using the Student’s t-test
or Tukey’s method after analysis of variance (ANOVA).
The results were considered significantly different at
P <0.05.
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